| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T563 |
0-132 |
Sentence |
denotes |
Similarly, Zhao et al. (2020) studied antibody response in 173 clinically diagnosed COVID-19 patients with a median age of 48 years. |
| T564 |
133-285 |
Sentence |
denotes |
Among these, nine patients (three critical and six non-critical) studied longitudinally for the relation of antibody response with the disease severity. |
| T565 |
286-365 |
Sentence |
denotes |
Antibody titer was higher in the critical patients as compared to non-critical. |
| T566 |
366-579 |
Sentence |
denotes |
This higher titer of antibodies was not reflected by the clearance of the virus, thus suggesting that antibody response in critical cases may be associated with worse disease outcome rather than protective effect. |
| T567 |
580-677 |
Sentence |
denotes |
However, like other studies, this study also suffers from the same limitation of low sample size. |
| T568 |
678-892 |
Sentence |
denotes |
In line with the notion that antibody response is higher in severe patients, a large population study (n = 30,576 persons from Iceland) (Gudbjartsson et al., 2020) conducted in Iceland revealed similar observation. |
| T569 |
893-1081 |
Sentence |
denotes |
The study provided a comprehensive account of the relation of antibody response concerning age, sex, body-mass index, drugs habits like smoking and the use of anti-inflammatory medication. |
| T570 |
1082-1250 |
Sentence |
denotes |
Results show that patients with smoking habit and who were on anti-inflammatory medication, had lower antibody levels, while body mass index had a positive association. |
| T571 |
1251-1440 |
Sentence |
denotes |
The data thus suggest that antibody response may not always favor clearance of the virus, but in some instances, higher antibody levels may make the patients more vulnerable to the disease. |
